Abstract: An inkjet apparatus comprises a stage, and an inkjet head positioned over the stage and including a plurality of nozzles through which ink including a plurality of particles is discharged. The inkjet head comprises a base portion constituting a main body of the inkjet head, a discharge portion adjacent to the base portion and including the plurality of nozzles, and an inner flow path between the base portion and the discharge portion and configured to accommodate the ink, wherein the base portion includes a first surface contacting the inner flow path, and at least a part of the first surface is at an incline.

Abstract: A display device includes: a display panel; and a color conversion panel overlapping the display panel, where the display panel includes a transistor disposed on a first substrate; a light-emitting element electrically connected to the transistor; and a passivation layer disposed between the transistor and the light-emitting element and including a first recess portion. The light-emitting element is disposed on the first recess portion, the color conversion panel includes a first color conversion layer, a second color conversion layer and a transmission layer, which are disposed between a second substrate and the display panel, and at least one selected from the first color conversion layer, the second color conversion layer and the transmission layer overlaps the first recess portion.

Abstract: A display device includes a first substrate, a first electrode above the first substrate, a pixel-defining film above the first electrode, and defining an emission area, a light-emitting layer above the first electrode and the pixel-defining film, a second electrode above the light-emitting layer, a thin-film encapsulation structure above the second electrode, and including an organic film defining an opening, and a color control layer above the thin-film encapsulation structure in the opening.

Abstract: The present invention relates to a composition for diagnosing cancer metastasis comprising Ubiquitin C-terminal hydrolase-L1 (UCH-L1), a use of UCH-L1 for diagnosing cancer metastasis and a method for diagnosing cancer metastasis using the same; a composition for suppressing cancer metastasis comprising an inhibitor of UCH-L1, a use of an inhibitor of UCH-L1 for suppressing cancer metastasis and a method of suppressing cancer metastasis using the same; a composition for screening a cancer metastasis inhibitor comprising UCH-L1 protein, a use of UCH-L1 protein for screening a cancer metastasis inhibitor and a method of screening cancer metastasis inhibitor using the same; a composition for screening a cancer metastasis inhibitor comprising UCH-L1 gene, a use of UCH-L1 gene for screening a cancer metastasis inhibitor, a method of screening cancer metastasis inhibitor using the same. UCH-L1 is a key molecule to modulate cell migration including the cancer invasion according to their expressing level.